Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: From epithelium to endothelium

Biochemical Pharmacology

Volumn 83, Issue 6, 2012, Pages 695-704

  Alam, Shirjel R ^a   Newby, David E ^a   Henriksen, Peter A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiovascular; Elafin; Elastase; Neutrophil; Proteinase 3

Indexed keywords

ALPHA 1 ANTITRYPSIN; CATHELICIDIN; CD14 ANTIGEN; ELAFIN; FLAGELLIN; FRESELESTAT; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOBLASTIN; PLASMINOGEN; PROSTAGLANDIN E2; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; SERINE PROTEINASE INHIBITOR; SIVELESTAT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; BACTERICIDAL ACTIVITY; BLOOD VESSEL INJURY; CARDITIS; CELL DEATH; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIUM; FIBRINOLYSIS; FIBROBLAST; HEART INFARCTION; HUMAN; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THROMBOGENESIS; THROMBOSIS; TISSUE DISTRIBUTION; VASCULITIS;

EID: 84857059735     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.11.003     Document Type: Note

References (114)

1. N. Borregaard, and J.B. Cowland Granules of the human neutrophilic polymorphonuclear leukocyte Blood 89 1997 3503
2. W.L. Lee, and G.P. Downey Leukocyte elastase Physiological functions and role in acute lung injury Am J Respir Crit Care Med 164 2001 896
3. M. Si-Tahar, D. Pidard, V. Balloy, M. Moniatte, N. Kieffer, and A.V. Dorsselaer Human neutrophil elastase proteolytically activates the platelet integrin aIIbb3 through cleavage of the carboxyl terminus of the aIIb subunit heavy chain. Involvement in the potentiation of platelet J Biol Chem 272 1997 11636 11647 (Pubitemid 27184177)
4. D. Carden, F. Xiao, C. Moak, B.H. Willis, S. Robinson-Jackson, and S. Alexander Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins Am J Physiol: Heart Circ Physiol 275 1998 H385
5. L. Robert, A. Robert, and B. Jacotot Elastin-elastase-atherosclerosis revisited Atherosclerosis 140 1998 281 295 (Pubitemid 28535319)
6. A.M.G. Houghton, P.A. Quintero, D.L. Perkins, D.K. Kobayashi, D.G. Kelley, and L.A. Marconcini Elastin fragments drive disease progression in a murine model of emphysema J Clin Invest 116 2006 753
7. W. Westlin, and M. Gimbrone Jr. Neutrophil-mediated damage to human vascular endothelium Role of cytokine activation Am J Pathol 142 1993 117
8. S.M. Frisch, and H. Francis Disruption of epithelial cell-matrix interactions induces apoptosis J Cell Biol 124 1994 619
9. E.M. Mtairag, X. Houard, S. Rais, C. Pasquier, M. Oudghiri, and M.P. Jacob Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions Arterioscler Thromb Vasc Biol 22 2002 1824
10. A. Garcia-Touchard, T.D. Henry, G. Sangiorgi, L.G. Spagnoli, A. Mauriello, and C. Conover Extracellular proteases in atherosclerosis and restenosis Arterioscler Thromb Vasc Biol 25 2005 1119
11. S. Chakraborti, M. Mandal, S. Das, A. Mandal, and T. Chakraborti Regulation of matrix metalloproteinases: an overview Mol Cell Biochem 253 2003 269 285
12. Y. Okada, and I. Nakanishi Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G FEBS Lett 249 1989 353 356 (Pubitemid 19143491)
13. Y. Okada, S. Watanabe, I. Nakanishi, J. Kishi, T. Hayakawa, and W. Watorek Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases FEBS Lett 229 1988 157 160 (Pubitemid 18058758)
14. V. Fontaine, Z. Touat, E.M. Mtairag, R. Vranckx, L. Louedec, and X. Houard Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus Am J Pathol 164 2004 2077
15. K. Wu, T. Urano, H. Ihara, Y. Takada, M. Fujie, and M. Shikimori The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis Blood 86 1995 1056
16. C. Duboscq, V. Genoud, M.F. Parborell, and L.C. Kordich Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation Thromb Res 86 1997 505 513 (Pubitemid 27314909)
17. S. Massberg, L. Grahl, M.L. von Bruehl, D. Manukyan, S. Pfeiler, and C. Goosmann Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases Nat Med 16 2010 887 896
18. M. Madjid, I. Awan, J.T. Willerson, and S.W. Casscells Leukocyte count and coronary heart disease: implications for risk assessment J Am Coll Cardiol 44 2004 1945 1956 (Pubitemid 39473277)
19. A. Buffon, L.M. Biasucci, G. Liuzzo, G. D'onofrio, F. Crea, and A. Maseri Widespread coronary inflammation in unstable angina N Engl J Med 347 2002 5 12 (Pubitemid 34728951)
20. T.P. Carroll, C.M. Greene, C.C. Taggart, A.G. Bowie, S.J. O'Neill, and N.G. McElvaney Viral inhibition of IL-1-and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells J Immunol 175 2005 7594
21. C. Coeshott, C. Ohnemus, A. Pilyavskaya, S. Ross, M. Wieczorek, and H. Kroona Converting enzyme-independent release of tumor necrosis factor and IL-1 from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 Proc Natl Acad Sci USA 96 1999 6261
22. M. Padrines, M. Wolf, A. Walz, and M. Baggiolini Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3 FEBS Lett 352 1994 231 235 (Pubitemid 24298425)
23. S. Sugawara, A. Uehara, T. Nochi, T. Yamaguchi, H. Ueda, and A. Sugiyama Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells J Immunol 167 2001 6568
24. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, and I. Migeotte Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 2003 977 985 (Pubitemid 37248614)
25. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity J Immunol 175 2005 487 493 (Pubitemid 40884353)
26. E. Nemoto, S. Sugawara, H. Tada, H. Takada, H. Shimauchi, and H. Horiuchi Cleavage of CD14 on human gingival fibroblasts cocultured with activated neutrophils is mediated by human leukocyte elastase resulting in down-regulation of lipopolysaccharide-induced IL-8 production J Immunol 165 2000 5807 5813
27. R.W. Vandivier, V.A. Fadok, P.R. Hoffmann, D.L. Bratton, C. Penvari, and K.K. Brown Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis J Clin Invest 109 2002 661 670 (Pubitemid 34204845)
28. S. Sadallah, C. Hess, S. Miot, O. Spertini, H. Lutz, and J.A. Schifferli Elastase and metalloproteinase activities regulate soluble complement receptor 1 release Eur J Immunol 29 1999 3754 3761 (Pubitemid 29527825)
29. P.A. Henriksen, M. Hitt, Z. Xing, J. Wang, C. Haslett, and R.A. Riemersma Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli J Immunol 172 2004 4535
30. J.M. Devaney, C.M. Greene, C.C. Taggart, T.P. Carroll, S.J. O'Neill, and N.G. McElvaney Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4 FEBS Lett 544 2003 129 132 (Pubitemid 36628048)
31. A. Uehara, K. Muramoto, H. Takada, and S. Sugawara Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2 J Immunol 170 2003 5690
32. A. Uehara, S. Sugawara, K. Muramoto, and H. Takada Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2 J Immunol 169 2002 4594
33. A.J. Leger, L. Covic, and A. Kuliopulos Protease-activated receptors in cardiovascular diseases Circulation 114 2006 1070
34. N. Asokananthan, P.T. Graham, J. Fink, D.A. Knight, A.J. Bakker, and A.S. McWilliam Activation of protease-activated receptor PAR-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells J Immunol 168 2002 3577
35. A.C. Chin, W.Y. Lee, A. Nusrat, N. Vergnolle, and C.A. Parkos Neutrophil-mediated activation of epithelial protease-activated receptors-1 and-2 regulates barrier function and transepithelial migration J Immunol 181 2008 5702
36. R. Ramachandran, K. Mihara, H. Chung, B. Renaux, C.S. Lau, and D.A. Muruve Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2) J Biol Chem 286 2011 24638
37. A. Belaaouaj, K.S. Kim, and S.D. Shapiro Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase Science 289 2000 1185 1188
38. J. Tkalcevic, M. Novelli, M. Phylactides, J.P. Iredale, A.W. Segal, and J. Roes Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G Immunity 12 2000 201 210 (Pubitemid 30398634)
39. A. Belaaouaj, K.S. Kim, and S.D. Shapiro Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase Science 289 2000 1185
40. A. Belaaouaj, R. McCarthy, M. Baumann, Z. Gao, T.J. Ley, and S.N. Abraham Mice lacking neutrophil elastase reveal impaired host defense against Gram negative bacterial sepsis Nat Med 4 1998 615 618 (Pubitemid 28237363)
41. T.O. Hirche, R. Benabid, G. Deslee, S. Gangloff, S. Achilefu, and M. Guenounou Neutrophil elastase mediates innate host protection against Pseudomonas aeruginosa J Immunol 181 2008 4945 4954
42. + flux Nature 416 2002 291 297 (Pubitemid 34260237)
43. A.J. Standish, and J.N. Weiser Human neutrophils kill Streptococcus pneumoniae via serine proteases J Immunol 183 2009 2602
44. R.I. Lehrer, and T. Ganz Cathelicidins: a family of endogenous antimicrobial peptides Curr Opin Hematol 9 2002 18 22 (Pubitemid 34025307)
45. J.M. Sallenave The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease Respir Res 1 2000 87 92
46. B. Korkmaz, S. Attucci, M.L. Jourdan, L. Juliano, and F. Gauthier Inhibition of neutrophil elastase by 1-protease inhibitor at the surface of human polymorphonuclear neutrophils J Immunol 175 2005 3329
47. C.A. Owen, M.A. Campbell, P.L. Sannes, S.S. Boukedes, and E.J. Campbell Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases J Cell Biol 131 1995 775
48. A.B. Lentsch, H. Yoshidome, R.L. Warner, P.A. Ward, and M.J. Edwards Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion Gastroenterology 117 1999 953 961 (Pubitemid 29468239)
49. N.G. McElvaney, H. Nakamura, P. Birrer, C.A. Hebert, W.L. Wong, and M. Alphonso Modulation of airway inflammation in cystic fibrosis In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor J Clin Invest 90 1992 1296 1301
50. E.K. Silverman, and R.A. Sandhaus Clinical practice alpha1-antitrypsin deficiency N Engl J Med 360 2009 2749 2757
51. K. Hoshi, S. Kurosawa, M. Kato, K. Andoh, D. Satoh, and A. Kaise a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients Tohoku J Exp Med 207 2005 143 148 (Pubitemid 41601029)
52. N. Okayama, Y. Kakihana, D. Setoguchi, T. Imabayashi, T. Omae, and A. Matsunaga Clinical effects of a neutrophil elastase inhibitor, sivelestat, in patients with acute respiratory distress syndrome J Anesth 20 2006 6 10 (Pubitemid 43125773)
53. M. Ryugo, Y. Sawa, H. Takano, G. Matsumiya, S. Iwai, and M. Ono Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study Surg Today 36 2006 321 326
54. S. Tamakuma, M. Ogawa, N. Aikawa, T. Kubota, H. Hirasawa, and A. Ishizaka Relationship between neutrophil elastase and acute lung injury in humans Pulm Pharmacol Ther 17 2004 271 279 (Pubitemid 39345408)
55. B.G. Zeiher, A. Artigas, J.L. Vincent, A. Dmitrienko, K. Jackson, and B.T. Thompson Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study Crit Care Med 32 2004 1695 1702 (Pubitemid 39050520)
56. Y. Yoshimura, Y. Hiramatsu, Y. Sato, S. Homma, Y. Enomoto, and T. Jikuya ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation Ann Thorac Surg 76 2003 1234 1239 (Pubitemid 37204738)
57. M. Luisetti, C. Sturani, D. Sella, E. Madonini, V. Galavotti, and G. Bruno MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial Eur Respir J 9 1996 1482 1486 (Pubitemid 26233794)
58. O. Wiedow, J. Schröder, H. Gregory, J. Young, and E. Christophers Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence J Biol Chem 265 1990 14791
59. J.M. Sallenave, and A.P. Ryle Purification and characterization of elastase-specific inhibitor sequence homology with mucus proteinase inhibitor Biol Chem Hoppe-Seyler 372 1991 13 22
60. H. Molhuizen, H. Alkemade, P. Zeeuwen, G. De Jongh, B. Wieringa, and J. Schalkwijk SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking J Biol Chem 268 1993 12028
61. J. Sallenave, and A. Silva Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions Am J Respir Cell Mol Biol 8 1993 439
62. J. Schalkwijk, O. Wiedow, and S. Hirose The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core Biochem J 340 1999 569
63. C. Francart, M. Dauchez, A.J.P. Alix, and G. Lippens Solution structure of R-elafin, a specific inhibitor of elastase, J Mol Biol 268 1997 666 677 (Pubitemid 27208084)
64. K. Nara, S. Ito, T. Ito, Y. Suzuki, M.A. Ghoneim, and S. Tachibana Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed cementoinî J Biochem 115 1994 441
65. Y. Sumi, N. Inoue, H. Azumi, T. Seno, M. Okuda, and K. Hirata Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability Atherosclerosis 160 2002 31 39 (Pubitemid 34076643)
66. M. Tsunemi, Y. Matsuura, S. Sakakibara, and Y. Katsube Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution Biochemistry 35 1996 11570 11576 (Pubitemid 26303673)
67. M.L. Zani, S.M. Nobar, S.A. Lacour, S. Lemoine, C. Boudier, and J.G. Bieth Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre elafin (trappin 2) expressed in Pichia pastoris Eur J Biochem 271 2004 2370 2378 (Pubitemid 38813567)
68. R. Pfundt, M. Wingens, M. Bergers, M. Zweers, M. Frenken, and J. Schalkwijk TNF- and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway Arch Dermatol Res 292 2000 180 187 (Pubitemid 30237519)
69. S. Lee, S. Hirose, S. Park, J. Chi, S. Chung, and M. Mori Elafin expression in human fetal and adult submandibular glands Histochem Cell Biol 117 2002 423 430 (Pubitemid 34569327)
70. M. Zhang, Z. Zou, N. Maass, and R. Sager Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level Cancer Res 55 1995 2537
71. A.E. King, H.O.D. Critchley, J.M. Sallenave, and R.W. Kelly Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation J Clin Endocrinol Metab 88 2003 4426
72. J. Sallenave, A. Silva, M. Marsden, and A. Ryle Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines Am J Respir Cell Mol Biol 8 1993 126
73. J.M. Sallenave, J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes Am J Respir Cell Mol Biol 11 1994 733
74. F. Jin, C. Nathan, D. Radzioch, and A. Ding Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide Cell 88 1997 417 426 (Pubitemid 27131383)
75. J. Zhu, C. Nathan, and A. Ding Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor Biochim Biophys Acta (BBA): Mol Cell Res 1451 1999 219 223 (Pubitemid 29518238)
76. M.W. Butler, I. Robertson, C.M. Greene, S.J. O'Neill, C.C. Taggart, and N.G. McElvaney Elafin prevents lipopolysaccharide-induced AP-1 and NF-B activation via an effect on the ubiquitin-proteasome pathway J Biol Chem 281 2006 34730
77. A. Simpson, A. Maxwell, J. Govan, C. Haslett, and J.M. Sallenave Elafin (elastase-specific inhibitor) has anti-microbial activity against Gram-positive and Gram-negative respiratory pathogens FEBS Lett 452 1999 309 313 (Pubitemid 29301766)
78. J.W. McMichael, A. Roghanian, J. Lu, R. Ramage, and J.M. Sallenave The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses Am J Respir Cell Mol Biol 32 2005 443 452 (Pubitemid 40629330)
79. J.M. Sallenave, G. Cunningham, R. James, G. McLachlan, and C. Haslett Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin Infect Immun 71 2003 3766
80. P.A Henriksen, A. Devitt, Y. Kotelevtsev, and J.M. Sallenave Gene delivery of the elastase inhibitor elafin protects macrophages from neutrophil elastase-mediated impairment of apoptotic cell recognition FEBS Lett 574 2004 80 84 (Pubitemid 39200898)
81. J. Savill, I. Dransfield, C. Gregory, and C. Haslett A blast from the past: clearance of apoptotic cells regulates immune responses Nat Rev Immunol 2 2002 965 975 (Pubitemid 37323217)
82. A. Roghanian, S.E. Williams, T.A. Sheldrake, T.I. Brown, K. Oberheim, and Z. Xing The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity Am J Respir Cell Mol Biol 34 2006 634
83. G.M. Tremblay, J.M. Sallenave, E. Israel-Assayag, Y. Cormier, and J. Gauldie Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung Am J Respir Crit Care Med 154 1996 1092
84. J. Schalkwijk, I. Van Vlijmen, J. Alkemade, and G. De Jongh Immunohistochemical localization of SKALP/elafin in psoriatic epidermis J Invest Dermatol 100 1993 390 393 (Pubitemid 23105202)
85. J.E. Jordan, Z.Q. Zhao, and J. Vinten-Johansen The role of neutrophils in myocardial ischemiañreperfusion injury Cardiovasc Res 43 1999 860
86. P.R. Hansen Role of neutrophils in myocardial ischemia and reperfusion Circulation 91 1995 1872
87. J.L. Romson, B.G. Hook, S.L. Kunkel, G. Abrams, M. Schork, and B. Lucchesi Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog Circulation 67 1983 1016
88. C. Tiefenbacher, M. Ebert, F. Niroomand, S. Batkai, H. Tillmanns, and R. Zimmermann Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart Pflugers Arch Eur J Physiol 433 1997 563 570 (Pubitemid 27093116)
89. J.L. Dinerman, and J.L. Mehta Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance, J Am Coll Cardiol 16 1990 207 222 (Pubitemid 20217066)
90. T.J Mocatta, A.P. Pilbrow, V.A. Cameron, R. Senthilmohan, C.M. Frampton, and A.M. Richards Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J Am Coll Cardiol 49 2007 1993 2000 (Pubitemid 46734639)
91. 2+ Proc Natl Acad Sci USA 87 1990 9472
92. K.A. Reimer, C.E. Murry, and V.J. Richard The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? J Mol Cell Cardiol 21 1989 1225
93. W. Dreyer, L. Michael, M. West, C. Smith, R. Rothlein, and R. Rossen Neutrophil accumulation in ischemic canine myocardium Insights into time course, distribution, and mechanism of localization during early reperfusion Circulation 84 1991 400
94. Z.Q. Zhao, D.A. Velez, N.P. Wang, K.O. Hewan-Lowe, M. Nakamura, and R.A. Guyton Progressively developed myocardial apoptotic cell death during late phase of reperfusion Apoptosis 6 2001 279 290 (Pubitemid 32708522)
95. F.M. Sheridan, P.G. Cole, and D. Ramage Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model Circulation 93 1996 1784
96. T. Murohara, M. Buerke, and A.M. Lefer Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins Arterioscler Thromb Vasc Biol 14 1994 1509
97. R. Engler, G. Schmid-Schönbein, and R. Pavelec Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog Am J Pathol 111 1983 98
98. M.R. Litt, R.W. Jeremy, H.F. Weisman, J.A. Winkelstein, and L.C. Becker Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 min of ischemia. Evidence for neutrophil-mediated reperfusion injury Circulation 80 1989 1816
99. K. Ohta, T. Nakajima, A.Y.L. Cheah, S.H.E. Zaidi, N. Kaviani, and F. Dawood Elafin-overexpressing mice have improved cardiac function after myocardial infarction Am J Physiol: Heart Circ Physiol 287 2004 H286
100. J. Crinnion, S. Homer-Vanniasinkam, R. Hatton, S. Parkin, and M. Gough Role of neutrophil depletion and elastase inhibition in modifying skeletal muscle reperfusion injury Cardiovasc Surg (London, England) 2 1994 749
101. R. Hattori, K. Hamilton, R. Fugate, R. McEver, and P. Sims Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140 J Biol Chem 264 1989 7768
102. C.M. Dollery, C.A. Owen, G.K. Sukhova, A. Krettek, S.D. Shapiro, and P. Libby Neutrophil elastase in human atherosclerotic plaques: production by macrophages Circulation 107 2003 2829
103. T. Naruko, M. Ueda, K. Haze, A.C. van der Wal, C.M. van der Loos, and A. Itoh Neutrophil infiltration of culprit lesions in acute coronary syndromes Circulation 106 2002 2894
104. S. Baldus, C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, and T. Munzel Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440
105. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions, J Clin Invest 94 1994 437
106. S.H.E Zaidi, X.M. You, S. Ciura, S. O'Blenes, M. Husain, and M. Rabinovitch Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice J Clin Invest 105 2000 1687 1730
107. A.W. Barolet, N. Nili, A. Cheema, R. Robinson, M.K. Natarajan, and S. O'Blenes Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor Arterioscler Thromb Vasc Biol 21 2001 1269
108. E. Okamoto, T. Couse, H. De Leon, J. Vinten-Johansen, R.B. Goodman, and N.A. Scott Perivascular inflammation after balloon angioplasty of porcine coronary arteries Circulation 104 2001 2228 2235 (Pubitemid 33043305)
109. P.L. Jones, K.N. Cowan, and M. Rabinovitch Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease Am J Pathol 150 1997 1349
110. S.B. O'Blenes, S.H. Zaidi, A.Y. Cheah, B. McIntyre, Y. Kaneda, and M. Rabinovitch Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration Circulation 102 2000 III289 III295
111. S.H.E. Zaidi, X.M. You, S. Ciura, M. Husain, and M. Rabinovitch Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension Circulation 105 2002 516 521 (Pubitemid 34141711)
112. S.H. Zaidi, C.C. Hui, A.Y. Cheah, X.M. You, M. Husain, and M. Rabinovitch Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis J Clin Invest 103 1999 1211 1219 (Pubitemid 29207255)
113. R. Bolli, L. Becker, G. Gross, Jr.R. Mentzer, D. Balshaw, and D.A. Lathrop Myocardial protection at a crossroads: the need for translation into clinical therapy Circ Res 95 2004 125
114. http://www.clinicaltrialsregister.eu/ctr-search/Search for 2010-019527-58 [accessed 26.10.2011].